A trial exploring the use of a higher dose of Novo Nordisk's GLP-1 agonist semaglutide has shown that patients with obesity ...
Hosted on MSN51m
Hundreds hospitalised after 'serious reactions' to weight-loss drugs - 'It raises significant concerns'Hundreds of Britons are being rushed to hospital with serious reactions to weight-loss drugs, with cases surging by 46 per ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback